Skip to main content
. 2023 Dec 8;23:367. doi: 10.1186/s12893-023-02279-x

Table 5.

Imaging features and pathological characteristics of patients with GGOs

Variables GGO in Group A
n = 601
N(%)or Median
GGO in Group B
n = 1320
N(%)or Median
P value
NO. OF LESIONS, DETECTED PER PATIENT P < 0.05
 1 462 (76.9) 1165 (88.3)
 2 108 (18) 113 (8.6)
 3 25 (4.2) 30 (2.3)
 ≥ 4 6 (1.0) 12 (0.9)
RADIOLOGICAL SIZE OF SOLID COMPONENT (MM) P < 0.05
 Median 9 7
RADIOLOGICAL TUMOR SIZE (MM) P < 0.05
 Median 11 12
CTR P < 0.05
 0 463 (77.0) 1105 (83.7)
 > 0, < 0.5 63 (10.5) 110 (8.3)
 ≥ 0.5, < 1 75 (12.5) 105 (8)
PATHOLOGICAL STAGE P < 0.05
 AAH 16 (2.6) 58 (4.4)
 AIS 139 (23.2) 210 (15.9)
 MIA 121 (20.1) 432 (32.7)
 IAC 240 (40.1) 540 (41.0)
 Squamous cell carcinoma 3 (0.5) 3 (0.2)
 Small cell lung cancer 0 (0) 3 (0.2)
 Metastatic cancer 2 (0.3) 0 (0)
 Other malignant tumors 4 (0.6) 1 (0.1)
 Benign 76 (12.6) 73 (5.5)
TNM CLASSIFICATION P < 0.05
 0 150 (25) 246 (18.6)
 IA1 217 (36.1) 611 (46.3)
 IA2 146 (24.3) 332 (25.1)
 IA3 36 (6) 71 (5.4)
 IB 37 (6.2) 46 (3.5)
 IIA 0 (0) 1 (0.1)
 IIB 5 (0.8) 9 (0.7)
 IIIA 10 (1.6) 4 (0.3)

NO. number, AAH atypical adenomatous hyperplasia, AIS adenocarcinoma in situ, MIA microinvasive adenocarcinoma, IAC invasive adenocarcinoma